In the News

Hear from an MSK social worker about developing body confidence after cancer treatment.

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to <i>U.S. News & World Report</i> in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in <i>JAMA Oncology</i>.

Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.

Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.

MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.

Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.

Learn about George Bosl, who will become MSK's first ombudsperson.